- Home
- WULF vs LGND Comparison
WULF vs LGND Comparison
Compare WULF & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- LGND
- Stock Information
- Founded
- WULF 1952
- LGND 1987
- Country
- WULF United States
- LGND United States
- Employees
- WULF N/A
- LGND 68
- Industry
- WULF EDP Services
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- LGND Health Care
- Exchange
- WULF Nasdaq
- LGND Nasdaq
- Market Cap
- WULF 1.9B
- LGND 2.2B
- IPO Year
- WULF 1995
- LGND 1992
- Fundamental
- Price
- WULF $8.71
- LGND $153.79
- Analyst Decision
- WULF Strong Buy
- LGND Strong Buy
- Analyst Count
- WULF 8
- LGND 8
- Target Price
- WULF $8.44
- LGND $144.71
- AVG Volume (30 Days)
- WULF 49.8M
- LGND 139.7K
- Earning Date
- WULF 08-08-2025
- LGND 08-05-2025
- Dividend Yield
- WULF N/A
- LGND N/A
- EPS Growth
- WULF N/A
- LGND N/A
- EPS
- WULF N/A
- LGND N/A
- Revenue
- WULF $144,085,000.00
- LGND $181,488,000.00
- Revenue This Year
- WULF $45.98
- LGND $18.41
- Revenue Next Year
- WULF $83.67
- LGND $18.87
- P/E Ratio
- WULF N/A
- LGND N/A
- Revenue Growth
- WULF 19.82
- LGND 53.40
- 52 Week Low
- WULF $2.06
- LGND $81.74
- 52 Week High
- WULF $9.30
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- WULF 82.07
- LGND 69.43
- Support Level
- WULF $4.67
- LGND $137.14
- Resistance Level
- WULF $5.77
- LGND $157.54
- Average True Range (ATR)
- WULF 0.51
- LGND 6.05
- MACD
- WULF 0.22
- LGND 1.27
- Stochastic Oscillator
- WULF 98.79
- LGND 86.60
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.